IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Orodispersible tablet Based on amorphous surface solid dispersions of Roxithromycin

Author: NARENDRA YADAV, PRABHAT KUMAR UPADHYAY, MANISH KUMAR, BEENA KUMARI
Abstract: The aim of this study was to carry out the formation and characterization of amorphous solid dispersions (SDs) as orodispersible tablets (ODT) were investigated using roxithromycin as a poorly water-soluble drug. Surface solid dispersion was prepared by using the solvent evaporation method and the tablets are prepared by direct compression method. In the present study, different evaluation parameters were performed such as Drug Excipient Compatibility Study, Thin Layer Chromatographic Study. Evaluation of surface solid dispersion was done by calculating drug content, In-Vitro Dissolution of Surface Solid Dispersion (SSD), SEM, DSC. The prepared orodispersible tablets were also evaluated for all derived properties and in vitro release studies. And finally, comparison studies were carried out. Formulation F3 shows maximum dissolution among surface solid dispersion formulations. It has been seen by increasing the concentration the dissolution was increased. Mechanism of improvement of dissolution characteristics of Roxithromycin by SSD3 was adsorption on the surface of the carrier. Tablet formulation F3 made with Surface Solid Dispersion with a disintegration time of 11 seconds, high water absorption of 78% by weight, by wetting time 6 seconds and cumulative drug release of 98% proved to be higher than the tablet made with solid dispersion. Comparison of surface solid dispersion and an orodispersible tablet was done. Both the techniques are best proven in the solubility enhancement. Selected formulations from both the dosage form show 94 and 97 % drug release respectively.
Keyword: Roxithromycin, in-vitro drug release, orodispersible tablet, solvent evaporation, Thin Layer Chromatographic, solid dispersion.
DOI: https://doi.org/10.31838/ijpr/2019.11.04.089
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus